erratum | Q1348305 |
scholarly article | Q13442814 |
P356 | DOI | 10.1038/NRCLINONC.2017.86 |
P698 | PubMed publication ID | 28895571 |
P50 | author | Mark Emberton | Q63968187 |
P2093 | author name string | Andrew Vickers | |
Timothy Wilt | |||
Chris Parker | |||
Hashim U Ahmed | |||
Richard Stephens | |||
Matthew R Sydes | |||
Jan van der Meulen | |||
Clare Relton | |||
Richard Kaplan | |||
Rakesh Heer | |||
David Bottomley | |||
Tom Leslie | |||
Viktor Berge | |||
William Cross | |||
Lindsay Turnbull | |||
and the Prostate Cancer RCT Consensus Group | |||
P2860 | cites work | Can we deliver randomized trials of focal therapy in prostate cancer? | Q50243071 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Can we deliver randomized trials of focal therapy in prostate cancer? | Q50243071 |
P577 | publication date | 2017-09-12 | |
P1433 | published in | Nature Reviews Clinical Oncology | Q641640 |
P1476 | title | Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer? |
Q50243071 | Can we deliver randomized trials of focal therapy in prostate cancer? | corrigendum / erratum | P2507 |